| Name | Title | Contact Details |
|---|
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
Solace Pediatric Healthcare is a leading provider of pediatric occupational, physical, speech and feeding therapy services in the state of Colorado. They offer in-home and telehealth therapy services for infants and children with developmental delays o...
Atrium Health, formerly Carolinas HealthCare System, is a not for profit hospital network which operates hospitals, freestanding emergency departments, urgent care centers, and medical practices in the American states of North Carolina, South Carolina ...
Caring People offering 24 hour home care service for the elderly and help seniors daily living at home. Hire 24-hour caregivers for your loved one.
International Society for Medical Publication is a Briarcliff Manor, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.